← Browse by Condition
Medical Condition

relapsed or refractory mantle cell lymphoma mcl

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07082686 Phase 2
Recruiting

A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)

Enrollment
68 pts
Location
China
Sponsor
Beijing InnoCare Pharma Tech C...
View Trial →